Sip Wijchers: Is It Time to Use Ultrasound for Every AF Ablation Access?
Sip Wijchers, Cardiologist-electrophysiologist at Erasmus MC, shared a post on LinkedIn:
”We’ve optimized anticoagulation in AF ablation. But what about the puncture?
Vascular access complications remain the most common adverse event in AF ablation. And yet, many labs still rely on landmark-based femoral venous access.
The ULYSSES trial challenges that habit.
In 986 patients undergoing AF/LA tachycardia ablation, ultrasound-guided access reduced clinically relevant vascular complications from 3.3% to 0.6% (RR 0.19, p=0.002) (Schaack et al., 2026).
But the real signal may be elsewhere:
- Arterial puncture: 16% – 2%
- Failed venous access: 8.2% – 0.2%
- No increase in procedure time
This is not about marginal gains.
This is about predictability and safety at the very first step of the procedure.
And importantly, this aligns with decades of data across vascular access:
Ultrasound improves success and reduces complications in central lines, subclavian access, and femoral arterial puncture (Teja et al., 2024; Zawadka et al., 2023; Strauss et al., 2025).
So the real question is no longer does it help?
It’s:
Can we still justify not using it?
- Yes, the absolute risk reduction is modest.
- Yes, the trial was stopped early.
But when a low-cost, widely available tool reduces the most frequent complication of a high-volume procedure… the bar for “routine use” should be low.
Should ultrasound-guided femoral venous access now be the default in AF ablation?
Or is palpation still acceptable in experienced hands?
Curious how this is implemented in your lab.”

Stay updated with Hemostasis Today.
-
Nov 17, 2026, 15:26Hereditary Hemorrhagic Telangiectasia: The Molecular Connection Between Vascular Malformations and Bleeding
-
Nov 17, 2026, 14:54Cindy Neunert: Beyond Platelet Counts – Addressing Fatigue and Whole-Person Care in ITP
-
Nov 17, 2026, 14:44Strengthening Haemophilia Diagnosis Through Hands-On Laboratory Training – IAHAD
-
Nov 17, 2026, 14:40Platelet Membrane Protrusions Beyond Their Role in Hemostasis – JTH
-
Nov 17, 2026, 14:10Wolfgang Miesbach: Aspirin vs Anticoagulants – Who Needs More Than Aspirin?
-
Nov 17, 2026, 14:08Chaza Alaji: Soluble Transferrin Receptor – A Key to Uncovering Hidden Iron Deficiency
-
Nov 17, 2026, 14:03Shadi Tabibian: Fibrinogen – From Molecular Structure to Clinical Decision Making
-
Nov 17, 2026, 13:54Gabrielle Sarlon: Breaking the Silence on Menstrual Bleeding During Anticoagulant Therapy
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome